Skip to the page

Data / Drug companies / Unit Dose Solutions, Inc.

Unit Dose Solutions, Inc.: 87 products in the FDA NDC directory, labeler code 87441

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Unit Dose Solutions, Inc. (labeler code 87441) lists 87 products in the FDA National Drug Code Directory, covering 54 finished drugs by generic name. By type: 85 prescription drugs, 2 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 29, 2026.

The request: Watch Unit Dose Solutions, Inc. (FDA labeler code 87441): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
87441
Products in commercial distribution
87
Packages
87
Finished drugs by generic name
54
Prescription products
85
Over the counter products
2
Controlled substance products
Schedule III 6, Schedule IV 10
Started marketing in the last 12 months
84
Earliest marketing start
September 30, 1990
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)8698.9%
Over the counter monograph drugs11.1%

Products by type

TypeProductsShare
Prescription drugs8597.7%
Over the counter drugs22.3%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet5057.5%
Tablet, film coated1719.5%
Capsule1314.9%
Tablet, delayed release44.6%
Tablet, coated22.3%
Capsule, delayed release11.1%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Naproxen87441-092TabletGeneric drugs (ANDA)September 29, 2026
Lorazepam87441-091TabletGeneric drugs (ANDA)September 24, 2026
Clonazepam87441-090TabletGeneric drugs (ANDA)September 24, 2026
Tramadol Hydrochloride87441-089Tablet, coatedGeneric drugs (ANDA)September 23, 2026
Trazodone Hydrochloride87441-081TabletGeneric drugs (ANDA)July 9, 2026
Trazodone Hydrochloride87441-080TabletGeneric drugs (ANDA)July 9, 2026
Topiramate87441-079Tablet, film coatedGeneric drugs (ANDA)July 9, 2026
Sulfamethoxazole and Trimethoprim87441-078TabletGeneric drugs (ANDA)July 9, 2026
Ondansetron Hydrochloride87441-088Tablet, film coatedGeneric drugs (ANDA)July 8, 2026
Hydroxyzine pamoate87441-087CapsuleGeneric drugs (ANDA)July 8, 2026
Methocarbamol87441-086Tablet, coatedGeneric drugs (ANDA)July 8, 2026
Sertraline Hydrochloride87441-077Tablet, film coatedGeneric drugs (ANDA)July 8, 2026
Sertraline Hydrochloride87441-076Tablet, film coatedGeneric drugs (ANDA)July 8, 2026
Sertraline Hydrochloride87441-075Tablet, film coatedGeneric drugs (ANDA)July 6, 2026
Quetiapine fumarate87441-074TabletGeneric drugs (ANDA)July 6, 2026
Quetiapine fumarate87441-073TabletGeneric drugs (ANDA)July 6, 2026
Quetiapine fumarate87441-072TabletGeneric drugs (ANDA)July 2, 2026
Quetiapine fumarate87441-071TabletGeneric drugs (ANDA)July 2, 2026
Promethazine Hydrochloride87441-070TabletGeneric drugs (ANDA)July 1, 2026
Prednisone87441-069TabletGeneric drugs (ANDA)July 1, 2026
Prazosin Hydrochloride87441-068CapsuleGeneric drugs (ANDA)July 1, 2026
Prazosin Hydrochloride87441-067CapsuleGeneric drugs (ANDA)July 1, 2026
Pantoprazole Sodium87441-066Tablet, delayed releaseGeneric drugs (ANDA)July 1, 2026
Buprenorphine87441-082TabletGeneric drugs (ANDA)June 30, 2026
Ondansetron Hydrochloride87441-064Tablet, film coatedGeneric drugs (ANDA)June 30, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.